Status:
COMPLETED
Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Parkinson Disease
COVID
Eligibility:
All Genders
Brief Summary
The consequences of COVID-19 in these already fragile patients should be evaluated. It will be important to appreciate the confinement consequences imposed on the patient on the course and impact of t...
Detailed Description
Adaptation capacities are necessary to cope with the brutal and drastic changes imposed by the pandemic and its consequences. In Parkinson's disease, where there are routine situations with difficulti...
Eligibility Criteria
Inclusion
- Patient followed by a doctor from the Parkinson Expert Center of the Toulouse University Hospital, Lille, Paris, Rouen, Nimes, Reims, Besancon, Marseille
- And with idiopathic Parkinson's disease
- Patients hospitalized or in consultation between 16/03/2020 and 16/05/2020.
Exclusion
- Atypical parkinsonian syndrome
- Patient subject to a legal protection order (tutorship)
- Patient not wishing to answer questions
Key Trial Info
Start Date :
July 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 18 2020
Estimated Enrollment :
411 Patients enrolled
Trial Details
Trial ID
NCT04466839
Start Date
July 2 2020
End Date
December 18 2020
Last Update
September 14 2021
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Régionale Universitaire de Besançon
Besançon, France, 25030
2
Centre Hospitalier Universitaire Lille
Lille, France, 59037
3
Centre Hospitalier Universitaire de Marseille
Marseille, France, 13385
4
Centre Hospitalier Universitaire de Nîmes - Caremeau
Nîmes, France, 30029